Petco vs Pets at Home

8-K Financial Filing Analysis for Petco (2026-09-02)

On September 2, 2026, Petco Health and Wellness Company, Inc. filed a Form 8-K under Items 2.02 and 7.01 announcing its financial results for the second fiscal quarter ended August 1, 2026. The results were disclosed via a press release furnished as Exhibit 99.1, and management scheduled an investor webcast and conference call at 4:15 p.m. Eastern Time on the same day to discuss operational performance and financial outlook. While the specific numerical financial tables from the exhibit are not incorporated directly in the report body, the filing formally initiates the quarterly earnings reporting cycle for the omnichannel pet care retailer.

• Petco issued a press release on September 2, 2026, reporting quarterly financial results for the period ended August 1, 2026.
• Management hosted a live earnings webcast conference call on September 2, 2026, at 4:15 p.m. Eastern Time.
• Information in Items 2.02 and 7.01 and Exhibit 99.1 was furnished pursuant to Regulation FD and is not deemed filed under Section 18 of the Exchange Act.

10-Q Financial Filing Analysis for Petco (2026-09-04)

Petco Health and Wellness Company reported its Q2 fiscal 2026 results for the thirteen weeks ended August 1, 2026, generating net sales of $1.49 billion, essentially flat year-over-year (+0.05%), with comparable sales growing 0.6%. Operating income rose 11.1% to $47.81 million, benefiting from a $6.8 million net tariff refund under the IEEPA and margin discipline. Net income surged to $38.66 million from $13.97 million in the prior-year period, substantially aided by a $15.71 million income tax benefit following the completion of a Joint Committee on Taxation refund review. Operationally, growth in Services and Other (+3.6% YoY to $272.36 million) offset modest declines in Supplies and Companion Animals (-2.0%). Adjusted EBITDA increased 7.3% to $122.22 million, and first-half operating cash flow nearly doubled to $130.58 million, delivering Free Cash Flow of $60.80 million.

• Q2 net sales reached $1,489.22 million with 0.6% comparable sales growth; Services & Other revenue expanded 3.6% to $272.36 million.
• Operating income rose to $47.81 million (inclusive of a $6.8 million net IEEPA tariff refund) and Net Income jumped to $38.66 million, driven by a $15.71 million tax benefit.
• First-half Free Cash Flow expanded sharply to $60.80 million compared to $9.92 million in the prior-year period, supported by $130.58 million in operating cash flow.

Petco loyalty program costs millions in point redemptions

Petco's relaunched loyalty program, Petco Perks, led to a mid-single-digit millions impact on Q2 2026 net sales due to unexpectedly high customer point redemption volumes. CEO Joel Anderson noted the program's success, with redemptions exceeding projections. The company has since implemented guardrails on redemption velocity and will focus on personalization. Despite the impact, Petco reported its second consecutive quarter of same-store sales growth.

• Petco's Q2 2026 net sales were hit by 'mid-single-digit millions' due to high loyalty program redemptions.
• Petco Perks members earn 10 points per dollar spent, and 30 points per dollar on private label brands.
• 1000 points can be redeemed for a $1 discount.

8-K Financial Filing Analysis for Pets at Home (2026-09-28)

On September 27, 2026, PetMed Express, Inc. amended and restated its 2024 Inducement Incentive Plan to increase the number of common shares reserved for issuance by 500,000, bringing the total pool to 850,000 shares. This share reserve expansion specifically accommodates the inducement equity grant for new Chief Executive Officer Jeffrey Allen Willard, whose employment commenced on September 28, 2026. The grant comprises 250,000 shares of restricted stock and 250,000 performance share units pursuant to Nasdaq inducement award rules.

• Share reserve under the 2024 Inducement Incentive Plan was increased by 500,000 shares to an aggregate total of 850,000 shares.
• The 500,000-share increase funds an inducement grant for new CEO Jeffrey Allen Willard, consisting of 250,000 restricted shares and 250,000 performance share units.
• The amendment was effective September 27, 2026, ahead of the CEO's official start date on September 28, 2026.

Pets Foundation celebrates 20 years of helping pets and the people who love them

Pets at Home's corporate foundation is celebrating 20 years of helping pets and the people who love them...

8-K Financial Filing Analysis for Pets at Home (2026-09-17)

PetMed Express, Inc. announced the appointment of Jeffrey Allen Willard as Chief Executive Officer, President, and Director, effective September 28, 2026. Mr. Willard succeeds Leslie C.G. Campbell, who had been serving as Interim CEO and President since August 2025 and is stepping down from both roles and the Board to pursue retirement. Mr. Willard brings executive leadership and e-commerce experience from previous leadership roles at Stewart MacDonald, Casper Sleep, and Healthy Lifestyle Brands. In addition, the Board appointed independent director Justin Mennen as the new Board Chair, concurrently eliminating the Lead Independent Director role.

• Jeffrey Allen Willard appointed CEO, President, and Director effective September 28, 2026, receiving a base salary of $550,000, a $120,000 signing bonus, and a target performance bonus of 75% of base salary.
• Inducement equity awards include 250,000 restricted stock units vesting over 3 years and up to 250,000 performance stock units tied to 3-year relative TSR vs. S&P 600 Specialty Retail Index, plus future annual LTI targets of $750,000.
• Interim CEO and Board Chair Leslie C.G. Campbell is resigning effective September 28, 2026; independent director Justin Mennen has been elected as the new Chair of the Board.